Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

PAVmed (PAVM) Treasury Shares (2022 - 2025)

Historic Treasury Shares for PAVmed (PAVM) over the last 1 years, with Q4 2022 value amounting to $408000.0.

  • PAVmed's Treasury Shares changed N/A to $2.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.0 million, marking a year-over-year change of. This contributed to the annual value of $324431.0 for FY2024, which is 8612.02% down from last year.
  • Latest data reveals that PAVmed reported Treasury Shares of $2.0 million as of Q3 2025.
  • PAVmed's 5-year Treasury Shares high stood at $3.9 million for Q2 2024, and its period low was $322399.0 during Q2 2025.
  • For the 4-year period, PAVmed's Treasury Shares averaged around $1.8 million, with its median value being $2.1 million (2022).
  • In the last 5 years, PAVmed's Treasury Shares soared by 10818.55% in 2024 and then tumbled by 9172.79% in 2025.
  • Quarter analysis of 4 years shows PAVmed's Treasury Shares stood at $2.1 million in 2022, then grew by 11.76% to $2.3 million in 2023, then crashed by 86.12% to $324431.0 in 2024, then surged by 526.75% to $2.0 million in 2025.
  • Its Treasury Shares was $408000.0 in Q4 2022, compared to $408000.0 in Q3 2022 and $548000.0 in Q2 2022.